Cyclin-dependent kinase 5/p35/p39: A novel and imminent therapeutic target for diabetes mellitus

International Journal of Endocrinology

Volumn 2011, Issue , 2011, Pages

  Ahmed, Danish ^a   Sharma, Manju ^b  

^a SAM HIGGINBOTTOM UNIVERSITY OF AGRICULTURE   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(1H IMIDAZOL 5 YL)METHYL] 7 FLUORO 9H PYRIDO[3,4 B]INDOLE; 2 [4 (BENZYLAMINO) 1 ISOPROPYL 1H BENZO[D]IMIDAZOL 6 YLOXY]BUTAN 1 OL; 2,2 DICHLORO N [4 METHYL (6 PHENYL [1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZOL 3 YL)THIOPHEN 2 YL]ACETAMIDE; 2,2 DICHLORO N [5 (6,7 DIPHENYL 5H [1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZIN 3 YL) 4 METHYLTHIOPEN 2 YL]ACETAMIDE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 5 INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR; GLUCOSE TRANSPORTER; INSULIN; N [4 METHYL (6 PHENYL [1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZOL 3 YL)THIOPHEN 2 YL]ACETAMIDE; N [5 (6,7 DIPHENYL 5H [1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZIN 3 YL) 4 METHYLTHIOPEN 2 YL]ACETAMIDE; OLOMOUCINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P35; PROTEIN P39; ROSCOVITINE; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

DIABETES MELLITUS; DRUG BINDING; DRUG POTENCY; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; GENE; GENE EXPRESSION; HUMAN; HYPERGLYCEMIA; IC 50; INSULIN GENE; INSULIN RELEASE; INSULIN RESISTANCE; MOLECULAR DOCKING; NERVE CELL; NONHUMAN; PANCREAS CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW;

EID: 84855262907     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2011/530274     Document Type: Review

References (29)

1. Choi J. H., Banks A. S., Estall J. L., Kajimura S., Bostrm P., Laznik D., Ruas J. L., Chalmers M. J., Kamenecka T. M., Blher M., Griffin P. R., Spiegelman B. M., Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR 3 by Cdk5 Nature 2010 466 7305 451 456
2. Morgan D. O., Cyclin-dependent kinases: engines, clocks, and microprocessors Annual Review of Cell and Developmental Biology 1997 13 261 291 (Pubitemid 28034527)
3. Lew J., Huang Q. Q., Qi Z., Winkfein R. J., Aebersold R., Hunt T., Wang J. H., A brain-specific activator of cyclin-dependent kinase 5 Nature 1994 371 6496 423 426 (Pubitemid 24302557)
4. Tsai L. H., Delalle I., Caviness V. S., Chae T., Harlow E., p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 Nature 1994 371 6496 419 423 (Pubitemid 24302556)
5. Tang D., Yeung J., Lee K. Y., Matsushita M., Matsui H., Tomizawa K., Hatase O., Wang J. H., An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator Journal of Biological Chemistry 1995 270 45 26897 26903
6. Tsai L. H., Takahashi T., Caviness V. S., Harlow E., Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system Development 1993 119 4 1029 1040 (Pubitemid 23358574)
7. Ubeda M., Kemp D. M., Habener J. F., Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic -cells Endocrinology 2004 145 6 3023 3031 (Pubitemid 38686252)
8. Lilja L., Johansson J. U., Gromada J., Mandic S. A., Fried G., Berggren P. O., Bark C., Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca 2+ -dependent exocytosis Journal of Biological Chemistry 2004 279 28 29534 29541 (Pubitemid 38915834)
9. Wei F. Y., Nagashima K., Ohshima T., Saheki Y., Lu Y. F., Matsushita M., Yamada Y., Mikoshiba K., Seino Y., Matsui H., Tomizawa K., Cdk5-dependent regulation of glucose-stimulated insulin secretion Nature Medicine 2005 11 10 1104 1108 (Pubitemid 41486833)
10. Ozaki N., Shibasaki T., Kashima Y., Miki T., Takahashi K., Ueno H., Sunaga Y., Yano H., Matsuura Y., Iwanaga T., Takai Y., Seino S., cAMP-GEFII is a direct target of cAMP in regulated exocytosis Nature Cell Biology 2000 2 11 805 811
11. Jeffrey P. D., Russo A. A., Polyak K., Gibbs E., Hurwitz J., Massague J., Pavletich N. P., Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex Nature 1995 376 6538 313 320
12. Russo A. A., Jeffrey P. D., Pavletich N. P., Structural basis of cyclin-dependent kinase activation by phosphorylation Nature Structural Biology 1996 3 8 696 700 (Pubitemid 26260060)
13. Zukerberg L. R., Patrick G. N., Nikolic M., Humbert S., Wu C. L., Lanier L. M., Gertler F. B., Vidal M., van Etten R. A., Tsai L. H., Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth Neuron 2000 26 3 633 646
14. Matsuura I., Wang J. H., Demonstration of cyclin-dependent kinase inhibitory serine/threonine kinase in bovine thymus Journal of Biological Chemistry 1996 271 10 5443 5450 (Pubitemid 26083877)
15. Butler A. E., Janson J., Bonner-Weir S., Ritzel R., Rizza R. A., Butler P. C., -cell deficit and increased -cell apoptosis in humans with type 2 diabetes Diabetes 2003 52 1 102 110 (Pubitemid 36042113)
16. Gurlo T., Ryazantsev S., Huang C. J., Yeh M. W., Reber H. A., Hines O. J., O'Brien T. D., Glabe C. G., Butler P. C., Evidence for proteotoxicity in cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway American Journal of Pathology 2010 176 2 861 869
17. Stefani M., Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world Biochimica et Biophysica Acta 2004 1739 1 5 25 (Pubitemid 39647706)
18. Sharma A., Olson L. K., Robertson R. P., Stein R., The reduction of insulin gene transcription in HIT-T15 cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression Molecular Endocrinology 1995 9 9 1127 1134
19. Olson L. K., Sharma A., Peshavaria M., Wright C. V. E., Towle H. C., Robertson R. P., Stein R., Reduction of insulin gene transcription in HIT-T15 cells chronically exposed to a supraphysiologic glucose concentration is associated with loss of STF-1 transcription factor expression Proceedings of the National Academy of Sciences of the United States of America 1995 92 20 9127 9131
20. Leahy J. L., Cooper H. E., Deal D. A., Weir G. C., Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions Journal of Clinical Investigation 1986 77 3 908 915 (Pubitemid 16067964)
21. Kawamori D., Kajimoto Y., Kaneto H., Umayahara Y., Fujitani Y., Miyatsuka T., Watada H., Leibiger I. B., Yamasaki Y., Hori M., Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH 2 -terminal kinase Diabetes 2003 52 12 2896 2904 (Pubitemid 37466858)
22. Ubeda M., Rukstalis J. M., Habener J. F., Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity Journal of Biological Chemistry 2006 281 39 28858 28864 (Pubitemid 44507029)
23. Ishiguro K., Kobayashi S., Omori A., Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of CDK5 in bovine brain FEBS Letters 1994 342 2 203 208 (Pubitemid 24115197)
24. Stein G. S., Baserga R., Giordano A., Denhardt D. T., The Molecular Basis of Cell Cycle and Growth Control 1999 28 New York, NY, USA Wiley-Liss
25. Dhavan R., Tsai L. H., A decade of CDK5 Nature Reviews Molecular Cell Biology 2001 2 10 749 759 (Pubitemid 33679837)
26. Malumbres M., Barbacid M., To cycle or not to cycle: a critical decision in cancer Nature Reviews Cancer 2001 1 3 222 231 (Pubitemid 33741897)
27. Lalioti V., Pulido D., Sandoval I. V., Cdk5, the multifunctional surveyor Cell Cycle 2010 9 2 284 311
28. Okada S., Yamada E., Saito T., Ohshima K., Hashimoto K., Yamada M., Uehara Y., Tsuchiya T., Shimizu H., Tatei K., Izumi T., Yamauchi K., Hisanaga S. I., Pessin J. E., Mori M., CDK5-dependent phosphorylation of the Rho family GTPase TC10 regulates insulin-stimulated GLUT4 translocation Journal of Biological Chemistry 2008 283 51 35455 35463
29. Lalioti V., Muruais G., Dinarina A., van Damme J., Vandekerckhove J., Sandoval I. V., The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes Proceedings of the National Academy of Sciences of the United States of America 2009 106 11 4249 4253